Doctor profile · Federal record

Dr. Egils Bogdanovics, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Torrington, CT

  • NPI 1619065976
  • Accepts Medicare
  • MIPS 78.7 / 100 · 2023
  • 38 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
780 Litchfield St
Torrington, CT 067906268
(860) 496-2198
fax (860) 489-2482

Credentials & registration

NPPES · NUCC
NPI registered
October 2006 — 20 yrs on file
Profile last updated
March 7, 2023
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Connecticut #031266

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1619065976. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
849
Distinct HCPCS
4
Medicare allowed
$67,243
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 509 305 $102
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 140 69 $36
99213 Established patient office or other outpatient visit, 20-29 minutes 110 100 $69
76536 Ultrasound scan of head and neck soft tissue 90 88 $29

In context: peer comparison

Among 1 peers in this city , average services per provider: 212. This provider delivers 4.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$77,306
Transactions
246
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novo Nordisk Inc 35 $20,973.66
Dexcom, Inc. 34 $20,365.67
Bayer Healthcare Pharmaceuticals Inc. 40 $17,372.59
SANOFI-AVENTIS U.S. LLC 9 $8,256.06
Amgen Inc. 30 $4,767.45
Ascensia Diabetes Care Us Inc. 12 $3,525.50
Lilly USA, LLC 22 $408.47
Xeris Pharmaceuticals, Inc. 17 $365.75
AstraZeneca Pharmaceuticals LP 9 $168.75
Antares Pharma, Inc. 8 $162.90
Boehringer Ingelheim Pharmaceuticals, Inc. 10 $154.10
Novartis Pharmaceuticals Corporation 7 $136.31
ABBVIE INC. 5 $109.06
Ascendis Pharma Inc 4 $89.31
IBSA Pharma Inc. 4 $88.35

By nature of payment

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
$46,037
Compensation for serving as faculty or as a speaker for a medical education program
$16,278
Travel and Lodging
$5,552
Food and Beverage
$5,507
Consulting Fee
$3,900
Education
$32

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,797
Patients
862
Total drug cost
$1,995,925
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 595 174 $10,600
Synthroid (Levothyroxine Sodium) Brand 442 120 $57,037
Ozempic (Semaglutide) Brand 268 67 $554,493
Metformin Hcl Generic 261 81 $3,085
Jardiance (Empagliflozin) Brand 182 49 $259,770
Tresiba Flextouch U-200 (Insulin Degludec) Brand 166 55 $221,099
Januvia (Sitagliptin Phosphate) Brand 113 32 $146,172
Metformin Hcl Er (Metformin Hcl) Brand 102 38 $1,784
Novolog Flexpen (Insulin Aspart) Brand 100 50 $178,427
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 98 34 $119,636

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Egils Bogdanovics's medical specialty?
Dr. Egils Bogdanovics practices Endocrinology, Diabetes & Metabolism Physician in Torrington, CT.
Where does Dr. Egils Bogdanovics practice?
Dr. Egils Bogdanovics practices at 780 Litchfield St, Torrington, CT 067906268. Office phone: 8604962198.
What is Dr. Egils Bogdanovics's NPI?
Dr. Egils Bogdanovics's National Provider Identifier (NPI) is 1619065976, issued by NPPES.
Does Dr. Egils Bogdanovics accept Medicare assignment?
Yes. Dr. Egils Bogdanovics accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Egils Bogdanovics commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.